MyMD Pharmaceuticals Stock Price, News & Analysis
Company Description
MyMD Pharmaceuticals (NASDAQ: MYMD) is a publicly traded pharmaceutical preparation manufacturing company in the In Vitro & in Vivo Diagnostic Substances sector. The company has a market capitalization of $4.3M, ranking #6,788 among all listed U.S. companies by market cap.
MYMD stock has declined 93.5% over the past year. Shares last traded at $1.82.
This page provides a comprehensive overview of MYMD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
MyMD Pharmaceuticals (MYMD) stock last traded at $1.82. Over the past 12 months, the stock has lost 93.5%. At a market capitalization of $4.3M, MYMD is classified as a micro-cap stock with approximately 2.4M shares outstanding.
Latest News
MyMD Pharmaceuticals has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 5 with negative movement. Key topics include clinical trial, management, stock split. View all MYMD news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
MYMD Company Profile & Sector Positioning
MyMD Pharmaceuticals (MYMD) operates in the Pharmaceutical Preparation Manufacturing industry within the broader In Vitro & in Vivo Diagnostic Substances sector and is listed on the NASDAQ.